APA (7th ed.) Citation

I, C., P, F., L, M., Collins, I., Francis, P., & Mileshkin, L. (2012). Adjuvant trastuzumab in HER2-positive breast cancer. New England Journal of Medicine, 366(7), 664. https://doi.org/10.1056/NEJMc1112823

Chicago Style (17th ed.) Citation

I, Collins, Francis P, Mileshkin L, Ian Collins, Prudence Francis, and Linda Mileshkin. "Adjuvant Trastuzumab in HER2-positive Breast Cancer." New England Journal of Medicine 366, no. 7 (2012): 664. https://doi.org/10.1056/NEJMc1112823.

MLA (9th ed.) Citation

I, Collins, et al. "Adjuvant Trastuzumab in HER2-positive Breast Cancer." New England Journal of Medicine, vol. 366, no. 7, 2012, p. 664, https://doi.org/10.1056/NEJMc1112823.